Advice on ‘end-of-year’ submission dates for type I variations in 2026

European Medicines Agency Version 1 original current

Imported from official source

Marketing authorisation holders wishing to receive an outcome in 2026 should submit type IA annual updates, individual type IA and type IAIN variations, and super-groupings…

This version

Version
1 of 1
Recorded
October 03, 2026 20:30
Change
Initial
Content hash
2e3c165a5260ac16714a5094c32ef424
All versions
Revision history

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.